1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 12 Hits
  • 検索条件 : 絞込み (MeSH = Cytotoxicity Tests, Immunologic)
生物種 リソース名 タイトル
ヒト・動物細胞 B16 Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
ヒト・動物細胞 RCN-9(RCB0511) , NRK49F(RCB0112) Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model.
遺伝子材料 , ヒト・動物細胞 pCXN-2/Cremp (RDB02945) , RK13(RCB0183) A novel chicken membrane-associated complement regulatory protein: molecular cloning and functional characterization.
遺伝子材料 pFLAG-CMV-2-WT-human Akt2 (RDB06615). Internalization of CD239 highly expressed in breast cancer cells: a potential antigen for antibody-drug conjugates.
ヒト・動物細胞 PC-3(RCB2145) , A549(RCB0098) , LK-2(RCB1970) , EBC-1(RCB1965) , MS-1(RCB0725) , Lu-134-A(RCB0466) The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
ヒト・動物細胞 BALB/3T3 clone A31(RCB0005) Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity.
ヒト・動物細胞 K562(RCB0027) Valpha24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells: implications for immunotherapy.
ヒト・動物細胞 U-937 DE-4(RCB0435) Enzymatically depolymerized alginate oligomers that cause cytotoxic cytokine production in human mononuclear cells.
ヒト・動物細胞 Prevention of murine acute graft-versus-host disease by staphylococcal enterotoxin B treatment.
ヒト・動物細胞 B16 melanoma 4A5(RCB0557) Role of gamma delta TCR+ lymphocytes in the augmented resistance of trehalose 6,6'-dimycolate-treated mice to influenza virus infection.
遺伝子材料 , ヒト・動物細胞 pCAZ 2 (RDB01870) , YAC‐1(RCB1165) The administration of naked plasmid DNA into the liver induces antitumor innate immunity in a murine liver metastasis model.
遺伝子材料 AxCAmIL2 (RDB1402) Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells.